Cameron Turtle - Chief Executive Officer, Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
SYRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cameron Turtle since 12/26/2023

Holdings reported by Cameron Turtle for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 747K $530K $0.71 Feb 15, 2024 Direct
Stock Option (Right to Buy) 278K Feb 1, 2024 Direct Common Stock
Series A Preferred Stock 0 Nov 24, 2023 Direct Common Stock

Transactions reported by Cameron Turtle for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.